If you experience chronic fatigue, shortness of breath, or hair loss, or have a family history of iron disorders, hemochromatosis, or celiac disease, iron testing matters. Serum iron alone tells an incomplete story — what you really need is the full iron panel (serum iron, ferritin, transferrin saturation, and TIBC) to assess whether your fatigue comes from iron deficiency, iron overload, or normal metabolism.

Women of reproductive age, vegetarians, individuals with inflammatory conditions like rheumatoid arthritis, and those with a history of blood loss or chronic bleeding should consider baseline iron status assessment. Athletes and highly active individuals may also benefit from tracking iron, since endurance training increases iron losses.

• Reveals iron storage and transport capacity. Serum iron shows circulating iron bound to transferrin, but without ferritin and transferrin saturation, you cannot distinguish iron deficiency from iron overload or acute inflammation.

• Flags early iron deficiency anemia. When serum iron drops alongside low ferritin, it signals tissue iron depletion before hemoglobin falls.

• Identifies hereditary hemochromatosis. Elevated iron with high transferrin saturation points toward HFE mutations or iron overload disorder requiring urgent management.

• Clarifies inflammation's effect on iron. Iron drops acutely during inflammation and infection even with normal iron stores — reading the full panel distinguishes true deficiency from acute-phase response.

• Guides diagnosis of anemia of chronic disease. Low iron with high ferritin (and normal or elevated transferrin saturation) is the signature pattern of anemia driven by chronic inflammation, not iron shortage.

• Tracks response to iron supplementation or phlebotomy. Serial iron measurement with ferritin shows whether iron repletion or depletion therapy is working as expected.

How iron circulates in blood. Most dietary iron is absorbed in the proximal small intestine and stored as ferritin in the liver, spleen, and bone marrow. Circulating iron in blood (the "serum iron" measurement) is a tiny fraction of total body iron — most is bound to transferrin, a transport protein made by the liver. Transferrin-iron complexes carry iron to bone marrow (for hemoglobin synthesis), muscles (for myoglobin and mitochondrial respiration), and other organs. The liver tightly regulates iron absorption via hepcidin, a hormone that increases when iron stores are full and decreases when they're depleted.

Why serum iron fluctuates wildly. Serum iron shows extreme diurnal variation — highest in the morning (often 10–30 µmol/L) and dropping 40–50% by evening due to circadian shifts in hepcidin secretion and iron uptake by tissues. It also drops acutely during inflammation, infection, or stress because hepcidin rises, sequestering iron in storage sites and lowering circulating levels. A single serum iron measurement reflects today's inflammation status and time of day, not iron stores. This is why clinicians never interpret serum iron alone — the iron panel (ferritin for storage, transferrin saturation for iron relative to transport capacity, and TIBC as a proxy for transferrin) is the clinical standard.

• Early detection of iron deficiency before anemia develops. Iron-deficient erythropoiesis (low serum iron with low ferritin) precedes frank anemia and causes fatigue, reduced VO2 max, and impaired thyroid function years before hemoglobin falls. Catching it early preserves aerobic capacity and metabolic resilience.

• Identifies iron overload, a silent aging accelerator. Excess iron catalyzes free-radical damage via the Fenton reaction (iron + oxidative stress → tissue injury). Hereditary hemochromatosis and secondary iron overload drive cirrhosis, cardiomyopathy, diabetes, and premature aging — early detection via elevated transferrin saturation allows therapeutic phlebotomy to prevent organ damage.

• Distinguishes true iron deficiency from anemia of chronic disease. In chronic inflammation (autoimmune disease, obesity, metabolic syndrome), hepcidin rises and sequesters iron despite adequate stores. The iron panel reveals this pattern — low serum iron with high ferritin — and shifts the focus from iron supplementation (ineffective and sometimes harmful) to treating the underlying inflammation.

• Contextualizes fatigue and performance loss. Iron status shapes mitochondrial respiration, aerobic capacity, and energy-dependent cognition. Testing it within the full panel helps distinguish whether fatigue comes from iron shortage, overload, or a non-iron driver like thyroid dysfunction or systemic inflammation.

• Standard Swedish reference (vårdcentralen): Men approximately 10–30 µmol/L; women approximately 7–27 µmol/L (fasting, morning sample).

• Loovi optimal (longevity): 15–25 µmol/L for men; 12–22 µmol/L for women — the mid-to-upper range of normal, indicating robust iron stores and transport capacity without overload risk.

• Concern zones: Below 10 µmol/L suggests iron depletion (assess ferritin and transferrin saturation urgently); above 30 µmol/L raises overload questions (calculate transferrin saturation immediately).

Serum iron alone does not diagnose anything. Always interpret it alongside ferritin (> 30 ng/mL suggests adequate stores), transferrin saturation (normal ~30–35%; > 45% suggests overload), and TIBC (higher values correlate with iron deficiency). Morning fasting samples are essential — iron measured in the afternoon may be 40–50% lower than morning values, creating spurious deficiency signals.

Low serum iron (< 10 µmol/L). Low iron alone is not diagnostic. If paired with low ferritin (< 30 ng/mL), iron-deficiency anemia is likely — tissue iron is depleted. If paired with high ferritin and high transferrin saturation, the low iron reflects acute-phase suppression during inflammation; the body has iron stores but is sequestering it. If paired with high ferritin but normal or low transferrin saturation, anemia of chronic disease is the diagnosis. Iron supplementation is only appropriate for true iron-deficiency anemia (low iron + low ferritin); giving iron to someone with anemia of chronic disease worsens outcomes.

Optimal serum iron (15–25 µmol/L). Within this range, and especially when paired with ferritin 40–150 ng/mL and transferrin saturation 30–40%, iron stores and transport are in balance. Oxygen carrying capacity, mitochondrial function, and energy metabolism are supported. No deficiency or overload risk.

High serum iron (> 30 µmol/L). Elevated iron alone is not specific for iron overload. Calculate transferrin saturation: if > 45%, iron overload is probable (hereditary hemochromatosis, cirrhosis, chronic transfusion, or secondary iron overload from hemolysis). If transferrin saturation is normal or low despite high serum iron, recent iron supplementation, recent transfusion, or acute hemolysis may explain it. Very high iron (> 45 µmol/L) with markedly elevated transferrin saturation (> 60%) is urgent — refer for HFE genetic testing and liver assessment.

Factors that influence serum iron: Time of day (morning values ~40–50% higher than afternoon), recent meal (iron in food does not directly enter blood but is absorbed over hours), menstrual cycle phase (iron slightly lower luteal phase due to hepcidin fluctuation), acute infection or inflammation (iron plummets as hepcidin rises), recent phlebotomy or blood donation (iron drops acutely), recent iron supplementation (iron rises transiently), alcohol use (increases absorption and may raise iron), and liver disease (impairs hepcidin regulation).

• Iron deficiency: Chronic bleeding (menorrhagia, GI loss, occult bleeding), malabsorption (celiac disease, inflammatory bowel disease, post-bariatric surgery), inadequate dietary intake (strict vegetarian/vegan diet without proper supplementation or iron-rich foods), pregnancy and lactation (iron demands exceed intake), and prolonged intense endurance training (exercise-induced hematuria and GI microbleeding).

• Iron overload: Hereditary hemochromatosis (HFE mutations, homozygous C282Y most common), secondary iron overload from chronic transfusion (thalassemia, sickle cell, myelodysplasia), cirrhosis (impaired hepcidin regulation), chronic viral hepatitis (HCV, HBV), and African iron overload (genetic variant linked to high-iron staple foods in some regions).

• Inflammation and acute-phase response: Any acute infection, autoimmune disease flare (rheumatoid arthritis, lupus, inflammatory bowel disease), sepsis, recent surgery, or major trauma triggers hepcidin release, which sequesters iron and lowers serum iron despite adequate body stores.

• Metabolic and hormonal drivers: Insulin resistance and type 2 diabetes increase hepcidin, paradoxically lowering serum iron while raising ferritin (anemia of chronic disease pattern). Estrogen suppresses hepcidin; menopause gradually increases iron stores in women. Alcohol use increases iron absorption and may cause overload.

• Age and lifestyle: Older adults often have lower iron (mild age-related decline), post-menopausal women gradually accumulate iron (no menstrual losses). Vegetarians and vegans may have lower iron if diet lacks bioavailable sources (heme iron from meat, vitamin C co-factors for non-heme iron absorption).

• Nutrition — bioavailability matters more than quantity. Heme iron (from red meat, poultry, fish) is 15–35% absorbed; non-heme iron (from legumes, leafy greens, fortified grains) is only 2–10% absorbed unless paired with vitamin C (citrus, tomatoes, peppers enhance absorption) or separated from iron inhibitors (tannins in tea/coffee, phytates in whole grains, calcium supplements consumed at the same meal block absorption). Addressing deficiency usually requires either heme iron sources or deliberate non-heme iron + vitamin C pairing, not generic "iron-rich foods."

• Managing inflammation to normalize iron regulation. If anemia of chronic disease is the pattern (low serum iron with high ferritin), the driver is excess hepcidin from inflammation. Addressing sleep, reducing chronic stress, managing autoimmune disease, and lowering systemic inflammatory markers (assessed via hs-CRP) allows hepcidin to normalize and iron to circulate more freely. Iron supplementation alone does not help here.

• Pharmacology and supplementation — context dependent. Oral iron supplementation (ferrous sulfate, ferrous bisglycinate) works for true iron-deficiency anemia if absorption is intact; parenteral (IV) iron is needed if malabsorption prevents oral repletion. Iron overload is treated with phlebotomy (removing blood to deplete stored iron) or, if phlebotomy is contraindicated, with chelating agents (deferoxamine, deferasirox). Self-treatment with iron supplements without confirmed deficiency risks iron overload and free-radical damage.

• Training and blood management. Endurance athletes with marginal iron stores benefit from monitoring both serum iron and ferritin during heavy training blocks, since exercise increases iron losses (GI microbleeding, urinary iron, sweat). Iron supplementation may improve VO2 max and fatigue tolerance in deficient athletes; those with replete stores derive no benefit. Post-menopausal women and men should have iron checked before supplementing, as overload risk rises without menstrual iron losses.

The right lever depends on your pattern: true deficiency, inflammation-mediated suppression, or overload. A Loovi longevity doctor assesses your full iron panel (serum iron, ferritin, transferrin saturation, TIBC) to distinguish these and design an intervention that actually works.

A single serum iron value is not clinically actionable. Without ferritin, you cannot distinguish iron depletion from acute-phase suppression during inflammation. Without transferrin saturation (iron divided by TIBC), you cannot detect iron overload — you need both the numerator (iron) and denominator (transport capacity) to diagnose hemochromatosis or secondary overload. Without hemoglobin and hematocrit, you cannot assess whether iron deficiency has caused anemia or is still in the tissue-depletion phase.

Iron status intersects with inflammation (hs-CRP), metabolic health (HbA1c, fasting glucose), and liver function (AST, ALT, GGT, albumin) — chronic inflammation suppresses iron despite adequate stores, and liver disease impairs hepcidin regulation entirely. That context is why Loovi tracks 120+ biomarkers annually, not iron alone. You get a full picture: are your energy and fatigue driven by iron shortage, inflammation, metabolic dysfunction, or thyroid disease? A single marker cannot tell you. The Loovi membership combines your iron panel with related markers, physical fitness data (VO2 max, strength, mobility), and unrushed consultations with longevity doctors to map your actual bottlenecks and design a personal protocol that works.

Loovi membership: 120+ biomarkers tracked annually, drop-in blood tests at 80+ Swedish clinics, results in 3 days, unrushed 1-on-1 longevity doctor consultations, physical testing, and an evolving personalized health plan — from 295 SEK/month, Friskvårdsbidrag-approved.